Search Thermo Fisher Scientific
- Order Status
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
The vast majority of preimplantation genetic testing for aneuploidy (PGT-A) is performed using one of two NGS-based platforms, the VeriSeq-PGS platform from Illumina or the Ion ReproSeq-PGS platform from Thermo Fisher Scientific. However, there are few head-to-head data available comparing the two assays. Join us for this webinar, where Dr. Andrea will demonstrate how their team assessed the performance of these two platforms when selecting the assay that best suited the needs of their lab.
Learning Objectives:
Join us for our upcoming webinar to learn about our Role of Next Gen Sequencing in SARS CoV2 Outbreak Management.
Date | Friday, 11 December, 2020 |
Time | India: 10.00 AM IST Singapore & Taiwan 12:30 PM SGT Japan & Korea: 1:30 PM JST/KST Australia & New Zealand: 3:30 PM AEST |
Duration | 90 minutes |
Language | English |
Type | Online, including live Q&A session |
Dr Andrea Tzu- Hsuan Chuang
Lab Manager, Stork Fertility Centre
Learn more about fast, accurate NGS for coronavirus research at thermofisher.com/ngs-coronavirus.
For Research Use, Only. Not for use in diagnostic procedures.